Beyond Ozempic, Wegovy & Co.: Innovations in Obesity and Diabetes Treatment

Matthias Tschöp, a leading expert in diabetes and obesity research, has decoded gut-brain signals, leading to groundbreaking medications for weight reduction and blood sugar control. His work represents a turning point in the global obesity pandemic, offering hope for improved health outcomes.

In conversation with Laura Weisenburger, medical doctor and journalist, he'll delve into Qzempic, Wegovy, and related medications. The conversation will also explore the ongoing battle against prevalent conditions like obesity and diabetes, discussing potential next steps.